RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinic

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?

IQV shares rise 21.7% in a month as data assets, AI-enabled technology and strong cash flow support

Callan Family Office LLC bought a new position in IQVIA Holdings Inc. (NYSE: IQV) during the undefin

BioLife Solutions (NASDAQ: BLFS - Get Free Report) and IQVIA (NYSE: IQV - Get Free Report) are both

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinic

BlackRock Inc. bought a new position in IQVIA Holdings Inc. (NYSE: IQV) during the undefined quarter

Bruni J V and Co. Co. purchased a new position in IQVIA Holdings Inc. (NYSE: IQV) during the undefin

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinic

IQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidan

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

First Trust Advisors LP cut its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 55.4% in the u

RESEARCH TRIANGLE PARK, N.C. & BOSTON--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider

IQV's proprietary data platform and expanding clinical research business support growth, but high de

IQV shares jump after Q2 earnings beat, record bookings and higher 2026 guidance, but future gains h

Empowered Funds LLC increased its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 147.8% durin

IQVIA Holdings Inc. (NYSE: IQV - Get Free Report) insider Eric Sherbet sold 5,000 shares of the stoc

The transaction involved the disposal of 558 shares at an exact weighted-average price of $245.21 pe

The transaction involved the sale of 5,000 shares at $249.16 per share, representing a total value o

JP Morgan analyst Casey Woodring maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises

Stifel analyst Shlomo Rosenbaum maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the pri

TD Cowen analyst Charles Rhyee maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the pric

RBC Capital analyst Ryan Halsted maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises

BMO Capital analyst Sean Dodge maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises t

Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the

A deepening chip rout drags the Nasdaq while Coca-Cola and Sherwin-Williams beats power the Dow; oil

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting bet

Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-

IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $3.15 per share which beat the analyst consens

IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.

Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the pri

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the

Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax t

Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J

Morgan Stanley analyst Kallum Titchmarsh downgrades IQVIA Holdings (NYSE:IQV) from Overweight to

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and h

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research ser

IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.55-$12.85 to $12.65-$12.95 vs $12.

IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $2.90 per share which beat the analyst consens

Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Holdings (NYSE:IQV) with a Outperfo

IQVIA Holdings Inc. (NYSE:IQV), a leading global provider of clinical research services, commercial

TD Cowen analyst Charles Rhyee upgrades IQVIA Holdings (NYSE:IQV) from Hold to Buy and raises the

Barclays analyst Luke Sergott upgrades IQVIA Holdings (NYSE:IQV) from Equal-Weight to Overweight

RBC Capital analyst Ryan Halsted initiates coverage on IQVIA Holdings (NYSE:IQV) with a Outperfor

Charles River to sell CDMO, Cell Solutions, and European assets, raise 2026 earnings outlook as shar